Ambit Biosciences Corp
SEC CIK 1131543 · AMBI · last insider filing 2014-12-22
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Marchington Allan P | Director | filed 2013 - 2014 |
| Parkinson David Ross | Director | filed 2013 - 2014 |
| Foletta Mark G | Director | filed 2014 - 2014 |
| Martino Michael A | Director · President and CEO | filed 2013 - 2014 |
| Hasnain Faheem | Director | filed 2013 - 2014 |
| Hatfield Jeffrey S. | Director | filed 2014 - 2014 |
| Elms Steve | Director | filed 2013 - 2014 |
| Fleming Standish | Director | filed 2013 - 2014 |
| Bonita David P | Director | filed 2013 - 2014 |
| Peimer Isai | Director | filed 2013 - 2014 |
| Regan Joseph | Director | filed 2013 - 2013 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Fuhrman Alan | Chief Financial Officer | filed 2013 - 2014 |
| North Annette | Senior VP and General Counsel | filed 2013 - 2014 |
| Countouriotis Athena | Chief Medical Officer | filed 2013 - 2014 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.